• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Johnson & Johnson

Johnson & Johnson seeks to have $442 million antitrust verdict tossed out

July 8, 2025 By Chris Newmarker

Johnson & Johnson’s Biosense Webster subsidiary has asked a federal judge in Central California for a judgment as a matter of law to throw out a jury’s antitrust verdict. Last month, U.S. District Judge James V. Selna tripled the damages in the case to $442 million, a practice enabled under federal antitrust law. In May, […]

Filed Under: Cardiovascular, Featured, Legal News Tagged With: antitrust, Biosense Webster, Innovative Health, Johnson & Johnson, Johnson & Johnson MedTech

FDA warns on issue with J&J Abiomed pump controllers related to 3 deaths

July 3, 2025 By Sean Whooley

The FDA alerted providers that Abiomed issued updated instructions for use related to all of its Automated Impella Controllers (AICs). This notice comes as part of the FDA’s Communications Pilot to Enhance the Medical Device Recall Program. The FDA issues these warnings when it becomes aware of a high-risk issue. According to a notice, this […]

Filed Under: Cardiac Implants, Cardiovascular, Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance, Structural Heart Tagged With: Abiomed, FDA, Johnson & Johnson, Johnson & Johnson MedTech

Johnson & Johnson MedTech launches AI fund for surgery with Nvidia, AWS

June 25, 2025 By Sean Whooley

Johnson & Johnson MedTech today announced the launch of the Polyphonic AI fund for Surgery. The fund aims to help develop AI solutions that solve challenges before, during and after surgery. A coalition of companies joined this effort, including Nvidia and Amazon Web Services (AWS). The initiative builds on Johnson & Johnson MedTech’s work to […]

Filed Under: Artificial Intelligence (AI), Business/Financial News, Digital Health, Featured, Health Technology, Hospital Care, Machine Learning (ML), Robotic-Assisted, Surgical, Surgical Robotics Tagged With: Amazon Web Services, AWS, Johnson & Johnson, Johnson & Johnson MedTech, nvidia

Johnson & Johnson launches daily disposable multifocal toric contact lens

June 23, 2025 By Danielle Kirsh

Johnson & Johnson today announced it launched its Acuvue Oasys Max multifocal lens for astigmatism. The company said the new lens is intended for one-day use for patients with both astigmatism and presbyopia. Acuvue Oasys Max lens provides clear, stable vision at all distances and in various lighting conditions, as well as all-day comfort. The […]

Filed Under: Business/Financial News, Optical/Ophthalmic, Vision Tagged With: J&J, Johnson & Johnson

Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus

June 19, 2025 By Sean Whooley

Johnson & Johnson MedTech announced today that it launched new variable angle optimized locking technology (VOLT) plating systems. The launch includes VOLT distal radius (wrist) and VOLT proximal humerus 3.5 plating systems. According to a news release, the systems aim to address a critical gap in treating two common fractures. Johnson & Johnson MedTech said […]

Filed Under: Business/Financial News, Featured, Implants, Orthopedic Implants, Orthopedics Tagged With: Johnson & Johnson, Johnson & Johnson MedTech

Johnson & Johnson adds JPMorganChase president to its board

June 11, 2025 By Sean Whooley

Johnson & Johnson  announced today that it elected JPMorganChase President Daniel Pinto to its board of directors. Pinto, a prominent business leader, has more than three decades of financial expertise across critical leadership roles within JPMorganChase. In addition to serving as president at one of the world’s preeminent global financial services firms, he also serves […]

Filed Under: Business/Financial News Tagged With: Johnson & Johnson, Personnel Moves

Johnson & Johnson MedTech launches newest Ethicon surgical stapler

June 10, 2025 By Sean Whooley

Johnson & Johnson MedTech today announced the U.S. launch of its Ethicon 4000 surgical stapler. The company said the stapling technology can also aid in the future use of its highly anticipated Ottava surgical robot. Johnson & Johnson MedTech designed its latest stapler to manage tissue complexities and deliver exceptional staple line integrity. It aims […]

Filed Under: Featured, Robotic-Assisted, Surgical, Surgical Robotics Tagged With: Johnson & Johnson, Johnson & Johnson MedTech

Johnson & Johnson sees antitrust damages tripled to $442M

June 6, 2025 By Chris Newmarker

Johnson & Johnson must now pay $442 million in damages in an antitrust case over cardiac mapping catheter reprocessing. Federal law enables the tripling of antitrust damages, and that’s what U.S. District Judge James V. Selna did in his judgment yesterday. A federal jury in Selna’s court in Central California hit J&J’s Biosense Webster business […]

Filed Under: Featured, In-Depth Coverage, Legal News Tagged With: Biosense Webster, Innovative Health, Johnson & Johnson, Johnson & Johnson MedTech

Johnson & Johnson MedTech launches new Kincise 2 automated hip, knee surgical system

June 3, 2025 By Sean Whooley

Johnson & Johnson MedTech announced today that it launched its Kincise 2 surgical automated power tool system. The company designed its next-generation system to improve surgical efficiency and provide control. It aims to reduce the physical burden on surgeons compared to manual impaction in a range of procedures. Those include primary and revision hip and […]

Filed Under: Featured, Implants, Orthopedic Implants, Orthopedics, Surgical Tagged With: Johnson & Johnson, Johnson & Johnson MedTech

Johnson & Johnson reports positive Monarch robotic bronchoscopy data

May 28, 2025 By Sean Whooley

Johnson & Johnson MedTech today announced results from a study of its Monarch platform for robotic bronchoscopy procedures. Results from the TARGET study showed that clinicians could reach small and peripherally located lung nodules in more than 98% of cases with Monarch. They also biopsied those nodules with a safety profile compared to non-robotic bronchoscopy […]

Filed Under: Clinical Trials, Diagnostics, Health Technology, Oncology, Robotic-Assisted, Surgical, Surgical Robotics Tagged With: Johnson & Johnson, Johnson & Johnson MedTech

The biggest cardiovascular tech news out of EuroPCR 2025

May 23, 2025 By Sean Whooley

This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR 2025 in Paris. The latest edition of EuroPCR delivered updates on technologies like intravascular lithotripsy (IVL), replacement heart valves, drug-eluting stents and many, many more innovative offerings. Usual suspects in the cardiovascular space like Edwards, Johnson & […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Clinical Trials, Drug-Eluting Stents, Featured, Implants, Regulatory/Compliance, Replacement Heart Valves, Stents, Structural Heart, Ultrasound, Vascular Tagged With: Boston Scientific, cardiawave, Edwards Lifesciences, Elixir Medical, EuroPCR 2025, Johnson & Johnson, Johnson & Johnson MedTech, Medtronic, Meril, Meril Life Science, Shockwave Medical, TriCares

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 33
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy